Insights on the Animal Pharmaceuticals United States Market to 2027 - Featuring Bayer, Huvepharma and Sanofi Among Others - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Animal Pharmaceuticals Market Research Report by Type, by Product, by Application, by End User, by State - United States Forecast to 2027 - Cumulative Impact of COVID-19" report has been added to ResearchAndMarkets.com's offering.

The United States Animal Pharmaceuticals Market size was estimated at USD 3,175.43 million in 2020, is expected to reach USD 3,597.99 million in 2021, and is projected to grow at a CAGR of 10.23% to reach USD 6,282.66 million by 2027.

Competitive Strategic Window:

The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.

FPNV Positioning Matrix:

The FPNV Positioning Matrix evaluates and categorizes the vendors in the Animal Pharmaceuticals Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.

Market Share Analysis:

The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.

The report provides insights on the following pointers:

1. Market Penetration: Provides comprehensive information on the market offered by the key players

2. Market Development: Provides in-depth information about lucrative emerging markets and analyze penetration across mature segments of the markets

3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments

4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players

5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:

1. What is the market size and forecast of the United States Animal Pharmaceuticals Market?

2. What are the inhibiting factors and impact of COVID-19 shaping the United States Animal Pharmaceuticals Market during the forecast period?

3. Which are the products/segments/applications/areas to invest in over the forecast period in the United States Animal Pharmaceuticals Market?

4. What is the competitive strategic window for opportunities in the United States Animal Pharmaceuticals Market?

5. What are the technology trends and regulatory frameworks in the United States Animal Pharmaceuticals Market?

6. What is the market share of the leading vendors in the United States Animal Pharmaceuticals Market?

7. What modes and strategic moves are considered suitable for entering the United States Animal Pharmaceuticals Market?

Key Topics Covered:

1. Preface

2. Research Methodology

3. Executive Summary

4. Market Overview

5. Market Insights

5.1. Market Dynamics

5.1.1. Drivers

5.1.2. Restraints

5.1.3. Opportunities

5.1.4. Challenges

5.2. Cumulative Impact of COVID-19

6. Animal Pharmaceuticals Market, by Type

6.1. Introduction

6.2. Vaccine

6.3. Veterinary Drugs

7. Animal Pharmaceuticals Market, by Product

7.1. Introduction

7.2. Anti-Inflammatories

7.3. Bronchodilators

7.4. Ectoparasiticides

7.5. Endoparasiticides

8. Animal Pharmaceuticals Market, by Application

8.1. Introduction

8.2. Companion Animal

8.3. Poultry

9. Animal Pharmaceuticals Market, by End User

9.1. Introduction

9.2. Hospitals

9.3. Laboratories

9.4. Veternary Clinics

10. California Animal Pharmaceuticals Market

11. Florida Animal Pharmaceuticals Market

12. Illinois Animal Pharmaceuticals Market

13. New York Animal Pharmaceuticals Market

14. Ohio Animal Pharmaceuticals Market

15. Pennsylvania Animal Pharmaceuticals Market

16. Texas Animal Pharmaceuticals Market

17. Competitive Landscape

18. Company Usability Profiles

18.1. Aratana Therapeutics, Inc.

18.2. Bayer AG

18.3. BioPredic International

18.4. Boehringer Ingelheim International GmbH

18.5. Ceva Animal Health LLC - Biomune

18.6. Ceva Sante Animale

18.7. Dechra Pharmaceuticals PLC

18.8. Dechra Veterinary Products USA

18.9. Elanco Animal Health Inc.

18.10. Eli Lilly & Company

18.11. Huvepharma, Inc.

18.12. Liberty Pharma INC

18.13. Merck & Co., Inc.

18.14. Perrigo Company plc

18.15. Sanofi

18.16. Sparhawk Laboratories

18.17. Vetoquinol S.A.

18.18. Virbac SA

18.19. Zoetis Inc.

19. Appendix

For more information about this report visit https://www.researchandmarkets.com/r/qck6zm